Furthermore, we examined the prognostic significance of BTK expression and found that increased expression of BTK significantly correlates with worse overall survival (OS) in the non-MYCN amplified neuroblastoma cohort (Seeger dataset) (Figure 1D). The gene discussed is MYCN; the disease is neuroblastoma.